These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Development of a sheep challenge model for Rift Valley fever. Faburay B, Gaudreault NN, Liu Q, Davis AS, Shivanna V, Sunwoo SY, Lang Y, Morozov I, Ruder M, Drolet B, Scott McVey D, Ma W, Wilson W, Richt JA. Virology; 2016 Feb; 489():128-40. PubMed ID: 26748334 [Abstract] [Full Text] [Related]
3. Rift Valley Fever Phlebovirus Reassortment Study in Sheep. Balaraman V, Indran SV, Kim IJ, Trujillo JD, Meekins DA, Shivanna V, Zajac MD, Urbaniak K, Morozov I, Sunwoo SY, Faburay B, Osterrieder K, Gaudreault NN, Wilson WC, Richt JA. Viruses; 2024 May 30; 16(6):. PubMed ID: 38932172 [Abstract] [Full Text] [Related]
4. A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep. Faburay B, Wilson WC, Gaudreault NN, Davis AS, Shivanna V, Bawa B, Sunwoo SY, Ma W, Drolet BS, Morozov I, McVey DS, Richt JA. Sci Rep; 2016 Jun 14; 6():27719. PubMed ID: 27296136 [Abstract] [Full Text] [Related]
9. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids. Morrill JC, Mebus CA, Peters CJ. Am J Vet Res; 1997 Oct 14; 58(10):1110-4. PubMed ID: 9328663 [Abstract] [Full Text] [Related]
11. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle. Morrill JC, Mebus CA, Peters CJ. Am J Vet Res; 1997 Oct 14; 58(10):1104-9. PubMed ID: 9328662 [Abstract] [Full Text] [Related]
14. Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs. Busquets N, Lorenzo G, López-Gil E, Rivas R, Solanes D, Galindo-Cardiel I, Abad FX, Rodríguez F, Bensaid A, Warimwe G, Gilbert SC, Domingo M, Brun A. Antiviral Res; 2014 Aug 14; 108():165-72. PubMed ID: 24933081 [Abstract] [Full Text] [Related]
15. Development of a Rift Valley fever virus viremia challenge model in sheep and goats. Weingartl HM, Miller M, Nfon C, Wilson WC. Vaccine; 2014 Apr 25; 32(20):2337-44. PubMed ID: 24631070 [Abstract] [Full Text] [Related]
16. Evaluation of the Efficacy, Potential for Vector Transmission, and Duration of Immunity of MP-12, an Attenuated Rift Valley Fever Virus Vaccine Candidate, in Sheep. Miller MM, Bennett KE, Drolet BS, Lindsay R, Mecham JO, Reeves WK, Weingartl HM, Wilson WC. Clin Vaccine Immunol; 2015 Aug 25; 22(8):930-7. PubMed ID: 26041042 [Abstract] [Full Text] [Related]
18. Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy. Wichgers Schreur PJ, van Keulen L, Kant J, Kortekaas J. Vaccine; 2017 May 25; 35(23):3123-3128. PubMed ID: 28457675 [Abstract] [Full Text] [Related]
19. Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments. Ikegami T, Hill TE, Smith JK, Zhang L, Juelich TL, Gong B, Slack OA, Ly HJ, Lokugamage N, Freiberg AN. J Virol; 2015 Jul 25; 89(14):7262-76. PubMed ID: 25948740 [Abstract] [Full Text] [Related]